Navigation Links
CHRISTUS Health Selects Five Elsevier Clinical Decision Support Solutions to Transform Care Delivery for Patients, Physicians, Nurses and Pharmacists
Date:8/10/2009

PHILADELPHIA, August 10 /PRNewswire-FirstCall/ --

- Partnership with Elsevier Facilitates Continuation of System's Nine-Year "Journey to Excellence"; Elsevier Becomes Primary Information Source for Clinicians

Elsevier (http://www.elsevier.com), a world leader in healthcare and medical publishing and online solutions, today announced that Dallas-based CHRISTUS Health, one of the top 10 Catholic health systems in the U.S., will install five of Elsevier's online clinical decision support (CDS) solutions to meet the diverse and evolving clinical decision support needs of its physicians, nurses and pharmacists.

CHRISTUS opted for Elsevier's comprehensive, interdisciplinary and integrated suite of CDS solutions for pharmacy, medicine and nursing. Among the selected solutions are Clinical Pharmacology (http://www.clinicalpharmacology.com), which delivers expert drug information; ToxED 2.0 (http://www.toxed.com), which facilitates treatment of drug overdose emergencies; First Consult (http://www.firstconsult.com), which provides evidence-based answers for the point of care; MD Consult (http://www.mdconsult.com), which brings leading medical resources together in a single online service; and Mosby's Nursing Consult (http://www.nursingconsult.com), which helps nurses find answers to pressing clinical questions.

"Elsevier looks forward to providing CHRISTUS Health clinicians with CDS solutions that deliver timely, consistent, accurate information for enhanced diagnostic and treatment decision making," said Scott Wilson, Vice President, Clinical Decision Support Sales. "When physicians, nurses and pharmacists access the same high-level evidence-based content, they are better positioned to coordinate care, engage patients and families and improve quality, safety and efficiency."

Elsevier CDS solutions will be installed in 25 Texas hospitals within CHRISTUS Health, which is composed of more than 40 hospitals, inpatient and long-term care facilities, as well as multiple clinics, physician offices and healthcare services.

"CHRISTUS Health has been on its Journey to Excellence since 2000, and adoption of multiple Elsevier CDS solutions will enable progress in each of our directions of excellence: clinical quality, service delivery, business literacy and community value," said Thomas Royer, M.D., President and CEO of CHRISTUS Health. "CHRISTUS Health's ability to continue our Journey means providing our physicians, nurses, pharmacists and associates with advanced clinical decision support tools to deliver absolute excellence."

Other factors influencing CHRISTUS' decision to adopt multiple Elsevier solutions included its need to consolidate resources, save on costs, integrate solutions and allow physicians, nurses and pharmacists to navigate effortlessly between CDS products. For example, a clinician can move seamlessly from MD Consult to Clinical Pharmacology, without logging in and out of multiple programs, saving time and effort.

"CHRISTUS is convinced that online decision support solutions play a vital role in fulfilling the system's mission," Royer said. "The implementation and use of Elsevier's multiple solutions will help us to create services, process and structures that improve the health of individuals and local and global communities."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

About CHRISTUS Health

Headquartered in Dallas, CHRISTUS Health (http://www.christushealth.org) is a faith-based, not-for-profit health system comprised of more than 40 hospitals, inpatient and long-term care facilities as well as dozens of clinics, physician offices and health care services in more than 70 cities in Texas, Arkansas, Louisiana, Oklahoma, Utah and Mexico. To provide care and support for patients, the system employs 30,000 Associates, with 9,000 physicians on facility medical staffs. CHRISTUS Health is listed among the top ten Catholic health systems in the U.S.

    Contact: Tom Reller
             Director, Corporate Relations
             +1-215-239-3508
             T.Reller@Elsevier.com



'/>"/>
SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CHRISTUS Health New Mexico Region Focuses on Cost Management; Saves $1.8 Million
2. Statement of the Leapfrog Group on Hospital Overdose of Up to 17 Babies at CHRISTUS Spohn
3. Thomson Reuters Research Identifies Top U.S. Health Systems
4. Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results
5. Lifeclinic to Showcase Health Stations and Health Communicator at the National Association of Chain Drug Stores 2009 Pharmacy and Technology Conference
6. Ex-House Aging Committee Chief of Staff Bob Weiner Warns of Insurance Control Over Health Bill Outcome, Praises House Version, Disappointed by Senate; Weiner and Policy Analyst Jordan Osserman Offer Bills Prognosis
7. Expanding Health Coverage May Not Improve Access
8. Electronic Health Records Help Cardiac Patients Remain Healthy
9. AlloSource Chosen as Healthcare Finalist in 2009 Top Companies
10. More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation
11. Marathon Health Expands Midwest Presence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: